Tryptophan
(QIVBCDIJIAJPQS-VIFPVBQESA-N)
Structure
- SMILES
- OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N
- Type(s)
- Approved; Nutraceutical; Withdrawn
- ATC code(s)
- N06AX02
- Molecular Formula:
- C11H12N2O2
- Molecular Weight:
- 204.225
- Log P:
- 1.8226
- Hydrogen Bond Acceptor:
- 3
- Hydrogen Bond Donor:
- 3
- TPSA:
- 79.11
- CAS Number(s):
- 73-22-3
Synonym(s)
1.
Tryptophan
2.
Ardeydorm
3.
Ardeytropin
4.
L-Tryptophan
5.
L-Tryptophan-ratiopharm
6.
Levotryptophan
7.
Lyphan
8.
Naturruhe
9.
Optimax
10.
PMS-Tryptophan
11.
Trofan
12.
Tryptacin
13.
Tryptan
14.
Tryptophan Metabolism Alterations
15.
ratio-Tryptophan
16.
L Tryptophan
17.
L Tryptophan ratiopharm
18.
PMS Tryptophan
19.
ratio Tryptophan
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Arthralgia | FAERS: 2 | US FAERS | |
| 2 | Feeling abnormal | FAERS: 2 | US FAERS | |
| 3 | Amnesia | FAERS: 1 | US FAERS | |
| 4 | Anxiety | FAERS: 1 | US FAERS | |
| 5 | Burning sensation | FAERS: 1 | US FAERS | |
| 6 | Chest Pain | FAERS: 1 | US FAERS | |
| 7 | Dyspepsia | FAERS: 1 | US FAERS | |
| 8 | Headache | FAERS: 1 | US FAERS | |
| 9 | Mood swings | FAERS: 1 | US FAERS | |
| 10 | Pain | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 11 | Pruritus | FAERS: 1 | US FAERS | |
| 12 | Abdominal discomfort | Canada Vigilance: 3 | Canada Vigilance | |
| 13 | Angina Pectoris | Canada Vigilance: 1 | Canada Vigilance | |
| 14 | Asthenia | Canada Vigilance: 2 | Canada Vigilance | |
| 15 | Conversion disorder | Canada Vigilance: 1 | Canada Vigilance | |
| 16 | Dizziness | Canada Vigilance: 1 | Canada Vigilance | |
| 17 | Eosinophilia | Canada Vigilance: 2 | Canada Vigilance | |
| 18 | Eye pain | Canada Vigilance: 1 | Canada Vigilance | |
| 19 | Fatigue | Canada Vigilance: 1 | Canada Vigilance | |
| 20 | Glossitis | Canada Vigilance: 1 | Canada Vigilance | |
| 21 | Limb discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 22 | Musculoskeletal stiffness | Canada Vigilance: 1 | Canada Vigilance | |
| 23 | Myalgia | Canada Vigilance: 1 | Canada Vigilance | |
| 24 | Mydriasis | Canada Vigilance: 1 | Canada Vigilance | |
| 25 | Nausea | Canada Vigilance: 1 | Canada Vigilance | |
| 26 | Neuritis | Canada Vigilance: 1 | Canada Vigilance | |
| 27 | Palpitations | Canada Vigilance: 2 | Canada Vigilance | |
| 28 | Restlessness | Canada Vigilance: 1 | Canada Vigilance | |
| 29 | Tremor | Canada Vigilance: 1 | Canada Vigilance | |
| 30 | Vomiting | Canada Vigilance: 1 | Canada Vigilance | |
| 31 | Weight decreased | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.